European Union Drugs Agency - EUDA

11/02/2026

🔍🌍 How will emerging technologies shape the future of the drugs field?

Today and tomorrow, we are bringing together experts from security, public health, research and technology to explore how technological change could affect drug production and supply, consumption patterns, responses and our ability to detect change early.

🤝🧠 This workshop is the first thematic expert meeting of our presidency of the Justice and Home Affairs Agencies’ Network. It supports a approach by connecting insights across sectors and agencies.

The discussions taking place will feed into our final foresight study and into public case studies to be shared later this year.

🔗 Learn more about our foresight work: https://www.euda.europa.eu/activities/euda-foresight_en
🔗 Discover our JHAAN activities: https://www.euda.europa.eu/activities/jha_en

11/02/2026

Effective responses to stimulant use disorders remain one of the biggest treatment challenges in Europe and beyond. In our first webinar — delivered with the UNODC - United Nations Office on Drugs and Crime and the World Health Organization (WHO) — experts explored what is currently known about pharmacological approaches and where innovation is most needed.

🎥 You can now watch the full recording:
https://www.euda.europa.eu/media-library/euda-webinar-scaleup-initiative-scalable-interventions-treatment-and-care-stimulant-use-disorders_en

This session marked the start of our series of webinars, which will continue throughout 2026, focusing on scalable, evidence based interventions that countries can adapt to improve treatment and care pathways.

06/02/2026

🧩 Europe’s security challenges increasingly cut across policy areas. Issues such as drugs, organised crime, public health, technology, migration and community resilience are closely linked — and addressing them separately limits their impact.

That’s the idea behind : a joined‑up approach to building preparedness and resilient communities across Europe.

🤝 This week in Lisbon, we brought together contact points from the EU Justice and Home Affairs Agencies’ Network (JHAAN), alongside EU partners, to start turning this approach into concrete action under the EUDA’s JHAAN presidency this year.

By connecting expertise across agencies and sectors, we aim to anticipate risks earlier, respond more effectively and strengthen resilience where it matters most.

👉 Learn more about our JHAAN presidency and what’s ahead: https://www.euda.europa.eu/activities/jha_en

03/02/2026

✍️ Join our team in Lisbon!

We’re looking for a Procurement and financial management analyst (FG IV) to support the effective planning, ex*****on and monitoring of procurement and financial operations at our agency.

What we’re looking for:

🟣 At least 5 years of professional experience in procurement and financial operations
🟣 Proven experience working with financial management systems
🟣 Ability to work with multiple stakeholders in an EU/international environment

📅 Apply by: 5 March 2026 at 23:59 (Lisbon time)

🔗 Find out more here: https://www.euda.europa.eu/calls/2026/ca202601_en

EU Careers

30/01/2026

📰 The January edition of Drugnet Europe is out!

In this issue:
👤 New Executive Director Dr Lorraine Nolan joins the EUDA
🤝 Reitox Alliance operating framework published
⚠️ Three new synthetic cathinones to be controlled across the EU
🔬 Horizon Europe 2026–2027 research funding opportunities
🎓 First webinar focuses on stimulant use disorders
💼 New vacancy

👉 Read our January news round-up: https://mailchi.mp/euda/drugnet-europe-196-january2026

👉 Subscribe to Drugnet Europe: https://europa.us7.list-manage.com/subscribe?u=7661463396b2fc9d763392225&id=3f011a8795

30/01/2026

🔔 EU takes action to control three harmful new synthetic cathinones

This month, new EU legal measures entered into force to bring three harmful new psychoactive substances (NPS) under control across Europe. The substances — 2-MMC, 4-BMC and NEP — are now classified as controlled ‘drugs’ under EU law.

These measures follow EUDA risk assessments in 2025 and reports through the EU Early Warning System of rising availability and poisonings in Member States.

Why this matters:
⚠️ Synthetic cathinones continue to gain ground on Europe’s stimulant market
📈 Record imports, seizures and production sites dismantled across Member States
🔬 Increasing harms linked to their use

EU Member States now have six months to introduce national legislation controlling the substances.

👉 Read the full news item: euda.europa.eu/news/2026/eu-takes-action-control-three-harmful-new-drugs_en

📘 Learn more about synthetic cathinones: euda.europa.eu/topics/synthetic-cathinones_en

29/01/2026

📢 Just published: Reitox Alliance operating framework

Effective drug monitoring in Europe depends on strong cooperation with Member States. In a new publication out today, we outline key features of the Reitox Alliance, a new partnership framework between the EUDA and our national focal points.

Adopted by our Management Board in December 2025, the Reitox Alliance:
🔹 Replaces the previous framework in place since 2003
🔹 Aligns the network’s activities with our expanded mandate
🔹 Establishes Reitox as an integral part of the EUDA management structure

Building on decades of collaboration, the Reitox Alliance marks an important step in reinforcing Europe’s preparedness for drug related challenges and supporting a truly European response grounded in national expertise.

👉 Read our news item: https://www.euda.europa.eu/news/2026/new-reitox-alliance-operating-framework-published_en

📄 Read the Reitox Alliance operating framework: https://www.euda.europa.eu/publications/work-programmes-and-strategies/reitox-alliance-operating-framework_en

29/01/2026

🚨 New job opportunity at the EUDA!

We’re inviting experienced professionals to join us as a Seconded National Expert to contribute to our work at the intersection of drug policy, crime and European cooperation.

In this role, you’ll:
🧠 Contribute to policy and strategic analysis
📊 Work with data, trends and analytical tools
🤝 Collaborate with national and international partners
🌍 Represent the EUDA in expert meetings and professional exchanges

Deadline to apply: 31 March 2026 (23:59 Lisbon time)

👉 Apply now: https://www.euda.europa.eu/calls/2026/sne202601_en

EU Careers

29/01/2026

🤝 Strengthening cooperation with

We are pleased to welcome a delegation from Moldova this week to explore opportunities for future bilateral technical cooperation.

👥 The delegation includes high-level representatives from the Ministry of Health, the Ministry of the Interior and the national medicines agency — reflecting Moldova’s strong cross sectoral approach to drug monitoring and responses.

Moldova has been our partner since 2012. Our cooperation fully aligns with the EUDA International Cooperation Framework and our commitment to support the EU enlargement process by working closely with the EU Delegation in Moldova. Together, we aim to strengthen evidence-based drug policies and build sustainable capacities in partner countries.

🔗 Learn more about our cooperation with Moldova:
https://www.euda.europa.eu/about/partners/eu4md/moldova_en

🔗 Learn more about the EUDA International Cooperation Framework:
https://www.euda.europa.eu/publications/work-programmes-and-strategies/euda-international-cooperation-framework_en

28/01/2026

📥 European Data Protection Day marks an occasion to consider how much personal information you share online - often without even noticing.

You have the right to the protection of your personal data, including information about where you live, what you do online and in your private life.

Know your rights under EU Data Protection Law, exercise your rights, and take control of your digital life.

26/01/2026

⏰ 2 days to go!

Join our webinar on scalable interventions for stimulant use disorders.

📅 Date and time: 28 January 2026 🕛 12:00–13:30 Lisbon time (WET) 🕐 13:00–14:30 (CET)

👉 Register now: euda.europa.eu/event/2026/01/euda-webinar-scaleup-initiative-scalable-interventions-treatment-and-care-stimulant-use-disorders_en

💻 How can we scale up effective responses to stimulant use disorders?

Join our webinar: initiative — scalable interventions for the treatment and care of stimulant use disorders, part of a joint initiative by the UNODC - United Nations Office on Drugs and Crime, the World Health Organization (WHO) and the EUDA.

The webinar will explore:
✅ Current developments in pharmacological strategies for stimulant use disorders
✅ Insights from research and treatment outcomes
✅ Upcoming activities for 2026, including a scoping review for stimulant use disorder treatment

📅 Date and time: 28 January 2026 🕛 12:00–13:30 Lisbon time (WET) 🕐 13:00–14:30 (CET)

👉 Register now: euda.europa.eu/event/2026/01/euda-webinar-scaleup-initiative-scalable-interventions-treatment-and-care-stimulant-use-disorders_en

26/01/2026

✨ This month, Cyprus assumed the EU Presidency with the motto ‘An Autonomous Union. Open to the World’.

Over the six months, Cyprus will chair the Horizontal Working Party on Drugs, advancing a balanced, evidence-based and humane EU approach to drug policy.

Priorities include the new EU Drugs Strategy, drugs in criminal justice and prison settings, harm reduction and a strong EU voice at the UN Commission on Narcotic Drugs.

🤝 We look forward to supporting the Presidency with data, analysis and expertise throughout its mandate.

Read more on our website: euda.europa.eu/news/2026/cyprus-takes-over-eu-presidency-motto-%E2%80%98-autonomous-union-open-world%E2%80%99_en

🔗 Explore the Presidency’s priorities:
cyprus-presidency.consilium.europa.eu/en/news/the-programme-priorities-and-logo-of-the-cyprus-presidency-of-the-council-of-the-eu-2026-unveiled/

📸 by Cyprus Presidency of the Council of the EU 2026